Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Free Report) has been assigned an average rating of “Moderate Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $105.91.
MMSI has been the topic of several research reports. Freedom Capital started coverage on Merit Medical Systems in a report on Tuesday, October 27th. They set a “hold” rating on the stock. Weiss Ratings upgraded Merit Medical Systems from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, October 12th. Canaccord Genuity Group increased their price target on Merit Medical Systems from $94.00 to $121.00 and gave the stock a “buy” rating in a research report on Friday, October 30th. Zacks Research lowered Merit Medical Systems from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 19th. Finally, Raymond James Financial set a $104.00 price objective on Merit Medical Systems and gave the company an “outperform” rating in a report on Monday.
Check Out Our Latest Research Report on MMSI
Merit Medical Systems Trading Down 0.0%
Shares of MMSI opened at $84.39 on Monday. The stock has a market capitalization of $5.06 billion, a PE ratio of 31.73, a P/E/G ratio of 2.10 and a beta of 0.56. The company’s fifty day moving average is $87.79 and its 200 day moving average is $77.51. The company has a debt-to-equity ratio of 0.42, a quick ratio of 3.05 and a current ratio of 4.52. Merit Medical Systems has a fifty-two week low of $59.74 and a fifty-two week high of $94.85.
Merit Medical Systems (NASDAQ:MMSI – Get Free Report) last posted its quarterly earnings data on Thursday, October 29th. The medical instruments supplier reported $1.12 EPS for the quarter, topping the consensus estimate of $1.04 by $0.08. The company had revenue of $416.24 million during the quarter, compared to analyst estimates of $410.56 million. Merit Medical Systems had a net margin of 9.94% and a return on equity of 14.12%. Merit Medical Systems’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.92 earnings per share. Sell-side analysts expect that Merit Medical Systems will post 3.86 earnings per share for the current fiscal year.
Insider Buying and Selling at Merit Medical Systems
In other news, insider Brian Lloyd sold 16,722 shares of the stock in a transaction on Monday, November 16th. The stock was sold at an average price of $86.33, for a total transaction of $1,443,610.26. Following the completion of the sale, the insider owned 60,132 shares in the company, valued at approximately $5,191,195.56. This represents a 21.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.70% of the company’s stock.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the company. Kilter Group LLC purchased a new position in Merit Medical Systems in the 2nd quarter valued at $25,000. Salomon & Ludwin LLC lifted its stake in shares of Merit Medical Systems by 140.8% in the third quarter. Salomon & Ludwin LLC now owns 537 shares of the medical instruments supplier’s stock worth $46,000 after buying an additional 314 shares in the last quarter. Harbor Investment Advisory LLC acquired a new position in Merit Medical Systems during the second quarter worth about $50,000. IFP Advisors Inc boosted its position in Merit Medical Systems by 88.6% during the third quarter. IFP Advisors Inc now owns 694 shares of the medical instruments supplier’s stock worth $60,000 after acquiring an additional 326 shares during the last quarter. Finally, Pinnacle Wealth Planning Services Inc. grew its stake in Merit Medical Systems by 84.0% during the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 784 shares of the medical instruments supplier’s stock valued at $68,000 after acquiring an additional 358 shares in the last quarter. 99.66% of the stock is owned by institutional investors and hedge funds.
Merit Medical Systems Company Profile
Merit Medical Systems develops, manufactures and markets medical devices used in diagnostic and interventional procedures. Its products support clinicians in areas including cardiology, radiology, oncology and endoscopy. The company’s portfolio includes devices and accessories for vascular access, diagnostic and therapeutic procedures, drainage, biopsy and embolization. Merit serves hospitals, clinics and other healthcare providers through direct sales and distribution channels. Founded in 1987 and headquartered in South Jordan, Utah, Merit Medical serves customers in the United States and internationally.
See Also
- Five stocks we like better than Merit Medical Systems
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
